Drug Profile
Meningococcal polysaccharide vaccine groups A C Y W135 - Bio-Med
Alternative Names: Meningococcal Polysaccharide Vaccine (Group A, C, Y and W135) - Bio Med; Quadri MeningoLatest Information Update: 09 Mar 2021
Price :
$50
*
At a glance
- Originator Bio-Med
- Class Antibacterials; Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Meningococcal infections
Most Recent Events
- 09 Mar 2021 Meningococcal polysaccharide vaccine groups A C Y W135 is still in phase III trial for Meningococcal infections (Prevention) in South America, North America, Europe, Japan, Australia, Africa, Asia (IM) (SC)
- 09 Mar 2021 Bio-Med completes a phase III trial for Meningococcal infections (Prevention) in South America, North America, Europe, Japan, Australia, Africa, Asia (IM) (SC) before March 2021 (UMIN000034298)